Vasamed, Inc.
VSMD · OTC
12/31/2005 | 12/31/2004 | 12/31/2003 | 12/31/2002 | |
|---|---|---|---|---|
| Revenue | $1,386 | $1,069 | $2,124 | $1,575 |
| % Growth | 29.7% | -49.7% | 34.9% | – |
| Cost of Goods Sold | $1,456 | $1,387 | $1,808 | $422 |
| Gross Profit | -$69 | -$318 | $316 | $1,153 |
| % Margin | -5% | -29.8% | 14.9% | 73.2% |
| R&D Expenses | $2,057 | $3,730 | $1,335 | $1,883 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,512 | $2,247 | $1,268 | $1,152 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4,673 | $5,977 | $2,603 | $3,035 |
| Operating Income | $4,742 | $6,295 | $2,287 | $1,882 |
| % Margin | 342.1% | 588.8% | 107.7% | 119.5% |
| Other Income/Exp. Net | -$4,742 | -$2,666 | -$2,287 | -$1,882 |
| Pre-Tax Income | $4,651 | $6,315 | $2,294 | $1,912 |
| Tax Expense | $146 | $127 | -$6 | -$30 |
| Net Income | -$4,888 | -$6,422 | -$2,281 | -$1,853 |
| % Margin | -352.6% | -600.7% | -107.4% | -117.6% |
| EPS | -1.31 | -1.85 | -0.71 | -0.67 |
| % Growth | 29.2% | -160.6% | -6% | – |
| EPS Diluted | -1.31 | -1.85 | -0.71 | -0.67 |
| Weighted Avg Shares Out | 3,718 | 3,472 | 3,192 | 2,747 |
| Weighted Avg Shares Out Dil | 3,718 | 3,472 | 3,192 | 2,747 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $0 | $147 | $0 | $0 |
| Depreciation & Amortization | $156 | $201 | $91 | $145 |
| EBITDA | -$4,574 | -$6,074 | -$2,196 | -$1,738 |
| % Margin | -330% | -568.1% | -103.4% | -110.3% |